EthicalMedTech
Aprovação Oficial
O Interstitial Lung Disease Multidisciplinary Meeting 2019 conta com o apoio da EthicalMedTech, após ter sido revisto pelo CVS (Conference Vetting Process), que avalia o programa e serviços oferecidos durante a reunião científica.
SEE ETHICALMEDTECH'S ENDORSEMENT OF THE ILD MEETING 2019
O que é o EthicalMedTech Conference Vetting System?
EthicalMedTech Conference Vetting System (CVS) is an independent entity that reviews the compliance of third-party educational events with both MedTech Europe Code of Ethical Business Practice and Mecomed Code of Business Practice to determine the appropriateness for companies which are members of MedTech Europe and Mecomed to sponsor Healthcare Professionals to participate in conferences. CVS aims to simplify and centralise decision-making for MedTech Europe and Mecomed members by establishing a single assessment procedure based on a set of criteria provisioned in the MedTech Europe Code of Ethical Business Practice. It also aims to harmonise the interpretation of the Code across the medical technology industry with the goals of greater consistency and transparency in industry behavior.